DISCIPLINES

Commercial Strategy

The best device doesn’t always win. The best-positioned one does. We help you choose the right market, define a differentiated position, and confirm the opportunity justifies the investment.

disciplines_LBB_commercial-strategy_color_800x800
Overview

Commercial strategy sets the direction for every commercial decision that follows. We help biomedical innovators size the opportunity, build a sustainable business model, and bring market input into product requirements before major capital is committed to clinical, regulatory, and launch work. The result is a plan investors can back and your team can execute.


What commercial strategy covers

Commercial strategy turns a promising device into a defensible business. Our work helps you size the market, define how you’ll generate revenue, and confirm that what you’re building is what the market will buy.

  • Market & Investor Strategy

    Market assessment, forecasting, fundraising narrative, commercial due diligence, partnerships, and exit readiness that build long-term value.

  • Business Model Strategy

    Revenue model, channel priorities, sales strategy, cost structure, and path to profitability, defined before you commit to a market.

  • Product Strategy

    Commercial input on product requirements and portfolio decisions, coordinated with your design and development teams.

Where commercial strategy shows up

Commercial strategy should lead at Foundation. That is where you set the market, business model, and investor case that later commercial decisions build on. It should then be revisited as evidence comes in and market conditions change.

PHASE 0

Foundation

Leads market assessment, business model, and investor strategy.

PHASE 1

Clinical Evidence

Supports the fundraising narrative and partnership strategy.

PHASE 2

Pivotal Development

Supports forecast and business model updates ahead of data readout.

PHASE 3

Regulatory Submission

Supports sales strategy and channel priorities ahead of clearance.

PHASE 4

Market Clearance

Supports channel partner selection and sales model.

PHASE 5

Commercial Launch

Supports forecast tracking and sales strategy adjustments.

PHASE 6

Growth

Leads portfolio, partnership, and exit readiness strategy.


The ROI on better commercial strategy

The commercial decisions you make early shape what you can raise, what you can charge, and how fast you reach revenue. A strategy grounded in real market data gives your device its best chance of winning the market, not just reaching it.

Stronger Fundraising

A market case and investor narrative that hold up to due diligence.

Focused Investment

Capital directed to the markets and indications worth pursuing.

Clear Path to Profitability

A business model with defined revenue, channels, and cost structure.

Faster Time to Revenue

Key commercial decisions settled before they can slow down launch.


Explore our disciplines

Every program draws on a different combination of our core disciplines to build the path from innovation to adoption.

  • disciplines_LBB_market-access_mono_800x800

    Market Access

    Build the path to payment and purchase, from coding and coverage to contracts.

  • disciplines_LBB_evidence-insights_mono_800x800

    Evidence & Insights

    Ground commercial decisions in what clinicians, payers, and buyers need to see.

  • disciplines_LBB_go-to-market_mono_800x800

    Go-to-Market

    Turn strategy into launch plans and marketing programs that drive adoption.

  • disciplines_LBB_commercial-strategy_mono_800x800

    Commercial Strategy

    Choose the right market, define a differentiated position, and confirm the opportunity justifies the investment

Content Card - Just Mighty - Launch - Two Color - Full (1920 x 1080)
Logo - Just Mighty - White Logo (400 x 400)

Your innovation Just Might change the world. But is your strategy up to the task? We help you turn Just Might into Just Mighty.